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Background/aim: A randomized, placebo-controlled, double-blind study was designed to investigate the effectiveness of ultrasound
therapy in primary knee osteoarthritis.
Materials and methods: Ninety patients between 40 and 65 years of age having grade 2 and 3 bilateral knee osteoarthritis enrolled in the
study were randomly assigned into 3 groups: continuous ultrasound, pulsed ultrasound, and placebo ultrasound. All patients were given
a home exercise program. Patients were evaluated at baseline, at the end of the treatment, and at the second month after the treatment
by a range of motion measurement, visual analog scale, Lequesne index for knee osteoarthritis, and Short Form-36 quality of life scale.
Results: The increase in the knee range of motion was similar in both ultrasound groups, while the change in the placebo group was
not statistically significant. Visual analog scale scores and Lequesne scores of the placebo group at the second month were significantly
greater than both ultrasound groups’ scores (P < 0.01 and P < 0.05, respectively).
Conclusion: Significant improvements in terms of pain, function, and quality of life scales were noted in both ultrasound groups in
comparison with the placebo group. No statistically significant difference was found in terms of efficacy between the continuous and
pulsed ultrasound.
Key words: Knee osteoarthritis, ultrasound, treatment

1. Introduction
Osteoarthritis (OA) is the most common joint disorder
and its incidence increases with age. Although it can
affect many joints in body, it mainly affects load-carrying
joints (1,2). Treatment of OA aims to reduce joint pain
and stiffness, preserve and improve joint mobility,
reduce physical limitations, increase the quality of life,
prevent further joint damage, and educate patients
about the course and results of the disease. Recent
guidelines recommend nonpharmacological modalities
like training, physical therapy, aerobics, strengthening
and aquatic exercises, weight loss, walking aids, thermal
modalities, transcutaneous electrical nerve stimulation,
and acupuncture. Surgical treatment is applied when
conservative methods fail. Ultrasound (US), with its
analgesic and antispasmodic effect on muscles, is one
of the widely used nonpharmacological treatment
methods for OA. US can be applied in 2 different modes,
continuous and pulsed. Thermal effects are predominant
in continuous mode application, which is advised for
* Correspondence: kpcserap@yahoo.com

the treatment of chronic cases. These thermal effects
are augmentation of blood flow, increased capillary
permeability, tissue metabolism and fibrous tissue
extensibility, muscle relaxation, and elevation of pain
threshold. In pulsed mode application, the heat that
occurs within the tissue with the first stimuli by US waves
disappears until the second stimuli; the mechanical
effect and deep penetration in the tissue provide a
micromassage effect and the degree of heat in the tissue
does not change. Pulsed mode US is preferred for the
treatment of acute and subacute cases. The nonthermal
effects are chemical activity increase, fluid flow increase,
and change in permeability of cell membranes, which
all provide analgesic effects (3–5). The literature about
comparison of different modes of US therapy in knee
OA is lacking and placebo-controlled trials regarding the
efficacy of therapeutic US are scarce. The present study
aims to examine and compare the effects of continuous
and pulsed US treatment on pain, function, and quality
of life in patients with knee OA.
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2. Materials and methods
Ninety patients between 40 and 65 years of age consulting
the outpatient clinic with the complaint of knee pain,
who were diagnosed with bilateral stage 2 and 3 primary
knee OA according to Kellgren–Lawrence criteria, were
enrolled in the study. Patients with secondary knee
OA; active synovitis; symptomatic hip, foot, and ankle
disease; neurologic deficits in a lower extremity; recent
knee trauma; history of intraarticular steroid and/or
hyaluronate injection in the past 6 months; history of
knee surgery or arthroscopy to the knee joint in the last
year; and application of physical treatment to the knee in
the last 3 months were excluded from the study. Written
informed consent was obtained from each patient.
Age, sex, body mass index (BMI), duration of
disease, profession, and educational levels of the patients
were recorded. Patients were evaluated by physical
examination and standing anteroposterior and lateral knee
roentgenograms. Each knee was staged according to the
Kellgren and Lawrence radiological stage (6). Complete
blood count, erythrocyte sedimentation rate, urinalysis, C
reactive protein, rheumatoid factor, and serum electrolytes
were tested.
The study protocol was a randomized, placebocontrolled, double-blind design. Previously prepared and
randomly enumerated closed envelopes that contained
the treatment methods were used for the randomization.
Patients were randomized into 3 groups, each group
consisting of 30 patients. In group 1 continuous US
(frequency: 1 MHz, intensity: 1.5 W/cm2, duration: 5 min)
and in group 2 pulsed US (frequency: 1 MHz, intensity: 1.5
W/cm2, mode: 1/5, duration: 5 min) were applied to the
anterior, medial, and lateral areas of the knees bilaterally.
In the third group placebo US was applied; the patients in
this group received exactly the same treatment procedure
as the treatment groups, except that the power switch was
off. All treatments were applied for 5 days a week for 2
weeks by the same 5-cm2 head US device (Enraf Nonius
Sono plus 492) and physiotherapist. All patients were
given a home exercise program at the beginning of the
treatment. Patients were instructed to perform the exercise
program, including quadriceps isometric exercises and
strengthening exercises, for 10 repetitions of the set, 3 times
a day for 8 weeks from the beginning of the treatment. To
ensure that exercises were learned properly, exercise cards
including the exercises were also handed out. The patients
were informed that they could take 500 mg of paracetamol
up to 3 times a day in case of pain during treatment.
The range of motion (ROM) of each knee was recorded;
a visual analog scale (VAS) was used to evaluate pain at
rest, sleep, and movement; and Lequesne functional index
values were recorded at each visit for the evaluation of
function. Quality of life evaluation was done using the
Short Form-36 (SF-36) and was recorded at baseline and
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at the second month. The VAS is a scale consisting of 10cm horizontal lines, with anchor points of 0 (no pain)
and 10 (maximum pain). The Lequesne index is a specific
evaluation standard developed for patients with knee and
hip OA (7) that evaluates maximum walking distance and
daily life activities. The SF-36 is one of the most commonly
used general health scales, used for a variety of health
status requirements, evaluating quality of life.
2.1. Statistics
A statistical package program was used to evaluate the
data obtained from the study. Descriptive statistical
methods (frequency, proportion, mean, and standard
deviation) were used in the evaluation of research data
as well as the Kolmogorov–Smirnov distribution test for
examining normal distribution. The Pearson chi-square
test was used in comparing qualitative data. In comparing
quantitative data, the Kruskal–Wallis test was used in
intergroup comparison of parameters when there was
more than one group and the Mann–Whitney U test was
used in determining the group causing a difference. The
Wilcoxon test was used for intragroup comparisons. The
results were calculated at the 95% confidence interval, P <
0.05 significance level, and P < 0.01 advanced significance
level.
3. Results
No study participant left the research project for any
reason. No side effects or complications were observed
during the treatment. Baseline characteristics of the
patients are shown in Table 1. The continuous US group
included 25 female and 5 male patients, the pulsed US
group included 24 female and 6 male patients, and the
placebo group included 26 female and 4 male patients.
The average age was 56.13 ± 6.61 years in the continuous
US group, 54.63 ± 6.53 years in the pulsed US group, and
57.76 ± 7.15 years in the placebo group. BMI was found to
be 32.31 ± 5.23 in the continuous US group, 31.15 ± 4.68
in the pulsed US group, and 30.91 ± 4.33 in the placebo
group. No statistically significant difference was found
between the 3 groups in terms of age, BMI, or sex (P >
0.05). The number of female patients in all 3 groups was
significantly higher than the number of male patients.
No statistically significant difference was found
between the knee pain duration of cases in the pulsed US
group and the continuous US group (P > 0.05). The average
duration of pain in the placebo group (5.10 ± 3.62 years)
was found to be significantly higher than in the cases in
the US groups (2.80 ± 2.31 years) (P < 0.05). There was no
statistically significant difference between groups in terms
of Kellgren and Lawrence radiological stage distribution
(P > 0.05). For the pulsed US and continuous US groups,
the number of patients with stage 3 OA was higher than
the ones with stage 2 OA.
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Table 1. Baseline characteristics of the patients.
Characteristics

Continuous US
(n = 30)

Pulsed US
(n = 30)

Placebo
(n = 30)

P

Age (years, mean ± SD)

56.13 ± 6.61

54.63 ± 6.53

57.76 ± 7.15

0.264

Duration (years, mean ± SD)

4.10 ± 3.15

2.80 ± 2.31

5.10 ± 3.62

0.028*

BMI (kg/m mean ± SD)

32.31 ± 5.23

31.15 ± 4.68

30.91 ± 4.33

0.632

Sex (female/male)

25/5

24/6

26/4

0.787

Kellgren–Lawrence radiological stage (II/III)

12/18

10/20

16/14

0.279

2

Data are presented as mean ± SD or number of patients. *P < 0.05.

The increase in active and passive ROM of both knees
for the pulsed and continuous US groups at the end of
the treatment was statistically significant in comparison
to baseline active and passive ROM scores (P < 0.01).
Additionally, the increase in active and passive ROM of
both knees at the second month after the treatment was
statistically significant in comparison to the ROM scores at
the end of treatment (P < 0.01). The increase in active and
passive ROM at the end of the treatment and at the second
month after treatment were similar in the continuous and
pulsed US groups (P > 0.05). The active and passive ROM
increase in the placebo group at the second month after the
treatment was significantly lower than in the continuous
and pulsed US groups (P < 0.01). The ROM increase in the
placebo group was not statistically significant (P > 0.05).
The decrease in VAS movement scores at the end of the
treatment and at the second month after treatment in the US
groups was statistically significant (P < 0.01). At the second
month after treatment, VAS rest, sleep, and movement
scores of the placebo group were significantly greater than
both US groups’ VAS scores (P < 0.01). No statistically
significant difference was found between continuous and
pulsed US groups in terms of VAS movement scores in the
second month (P > 0.05). In contrast to the US groups,
in the placebo group an increase was recorded in VAS
movement values at the second month after treatment in
comparison to the VAS movement scores at the end of the

treatment, and it was statistically significant (P < 0.01) as
shown in Table 2.
Continuous and pulsed US groups showed a statistically
significant increase in terms of the SF-36 physical
component scale at the second month after treatment in
comparison to baseline values (P < 0.01). There was no
statistically significant difference between US groups. The
increase in the second month scores of the placebo group
in terms of the SF-36 physical component scale was not
statistically significant (P > 0.05).
In terms of the SF-36 mental component scale, there
was a statistically significant increase in the continuous
and pulsed US groups at the second month after
treatment (P < 0.05). In the placebo group, the decrease
in mental component scale scores at the second month
after treatment in comparison to baseline scores was not
statistically significant (P > 0.05).
The decreases in Lequesne pain, walking distance,
daily life activity, and index scores in the continuous
and pulsed US groups were similar at the second month
after treatment. Lequesne pain, walking distance, daily
life activity, and index scores for the placebo group were
significantly higher than in the continuous and pulsed US
groups at the end of the treatment and at the second month
after treatment (P < 0.05). The change in the placebo group
was not significant, as shown in Table 3.

Table 2. Pain scores.
VAS movement (mm)

Continuous US
(n = 30)

Pulsed US
(n = 30)

Placebo
(n = 30)

P

Baseline

8.97 ± 1.45

8.60 ± 1.61

8.93 ± 1.44

0.598

At the end of the treatment

5.40 ± 1.79

5.17 ± 2.02

6.73 ± 2.89

0.020*

Second month after treatment

3.90 ± 2.54

3.83 ± 2.61

7.20 ± 2.66

0.000**

Data are presented as mean ± SD. *P < 0.05, **P < 0.001.
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Table 3. Lequesne index scores during the study.
Lequesne index score

Continuous US
(n = 30)

Pulsed US
(n = 30)

Placebo
(n = 30)

P

Baseline

13.20 ± 3.66

12.90 ± 2.73

12.37 ± 3.68

0.451

At the end of the treatment

8.15 ± 3.35

7.85 ± 2.75

10.50 ± 3.61

0.003**

Second month after treatment

5.45 ± 3.43

6.02 ± 3.14

11.73 ± 4.53

0.000**

Data are presented as mean ± SD. *P < 0.05, **P < 0.001.

4. Discussion
Treatment of OA aims to reduce joint pain and stiffness,
preserve and improve joint mobility, reduce physical
limitations, increase the quality of life, prevent further joint
damage, and educate patients about the course and results
of the disease. The use of physical treatment modalities
is important due to the considerable gastrointestinal and
cardiac side effects of pharmacological agents commonly
used in the treatment of OA, which is an important issue
especially for the geriatric patients.
US, which is among the most commonly used physical
treatment methods, is a deep heating modality with
analgesic and antispasmodic effects on muscles. The
analgesic efficacy of therapeutic US results from both
thermal and nonthermal effects. Thermal effects cause a
decrease in pain sensation by affecting tissue metabolism,
capillary permeability, pain threshold, and an increase
in tissue elasticity. Nonthermal effects decrease pain
sensation by stimulating tissue regeneration, changing cell
membrane permeability, and increasing the intracellular
calcium entrance to the neural system (3). Although US
is frequently used in the conservative management of
knee osteoarthritis, there is no consensus about mode of
application and the few studies in the literature about its
therapeutic efficacy report conflicting results.
Commonly observed clinical findings of knee OA are
pain, joint stiffness, decrease in ROM, and functional loss
(8,9). Knee pain, ROM, and functional indices (SF-36 and
Lequesne index) were evaluated in the present study. We
detected significant increase in active and passive ROM
at the end of the treatment and at the second month in
both US groups, whereas no statistical significance was
detected between continuous and pulsed US groups in
terms of ROM increase. Falconer et al. (10) examined the
effectiveness of US on joint stiffness and pain in patients
with knee OA and knee contracture. The patients were
divided into 2 groups; exercises and US treatment were
applied to one group and placebo to the other. A significant
recovery was observed in active ROM, pain, and walking
speed of both groups, of which the effects lasted for at least
2 months. They found no significant difference between
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groups in terms of ROM and reported that US treatment
had no contribution to exercises in patients with knee OA
and chronic knee contracture. The patients in Falconer et
al.’s study included patients with chronic knee contractures;
8 of them had total knee arthroplasty, and US was applied
for 3 min in duration and the dose was not constant. In
contrast to the aforementioned study, our study included
no patients with knee contracture and the applied US
treatment was at a constant dose for 5 min in duration. We
concluded that US treatment is effective in osteoarthritic
knees with no contractures in terms of increasing ROM.
Huang et al. examined the effectiveness of US on
isokinetic exercises in patients with knee OA. Their study
included 120 patients with knee OA who were divided
into 4 groups. Isokinetic stretching exercises were applied
in the first group, isokinetic stretching exercises and
continuous US were applied in the second group, and
isokinetic stretching exercises and pulsed US were applied
in the third group. The fourth group was a control group.
They reported an increase in ROM and walking speed in
the second and third groups; the highest recovery rates
in terms of walking speed and decrease in disability were
achieved in the third group. In conclusion, it was reported
that US treatment increased the efficacy of isokinetic
exercise and thus the functional improvement in patients
with knee OA. In contrast to our study, where we found
no difference between continuous and pulsed US groups,
Huang et al. reported a superior efficacy of pulsed US (11).
VAS scores at rest, sleep, and movement were evaluated
in the current study. Posttreatment VAS scores of the
placebo group at all times were significantly higher than
in the US groups. Continuous and pulsed US seem to have
similar efficacy in terms of pain reduction in knee OA.
Özgönelel et al. examined the clinical effects of therapeutic
US on patients with knee OA and conducted a randomized,
double-blind, placebo-controlled study including 67
patients who were divided into pulsed US treatment and
placebo treatment groups. They evaluated the patients
at the end of the treatment by the VAS movement scale,
Western Ontario and McMaster Universities Osteoarthritis
Index (WOMAC), and 50-m walking test. They reported a
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statistically significant difference in recovery in the pulsed
US group in terms of VAS movement, WOMAC, and 50-m
walking test in comparison to the placebo group (12).
The results of the current study are consistent with
the results of the aforementioned studies in confirming
the superiority of US treatments over placebos in the
treatment of knee OA. Our study differs in demonstrating
a relatively longer period of efficacy. Most of the
investigations regarding the efficacy of therapeutic US on
knee OA evaluate the immediate posttreatment results,
which gives information about short-term efficacy. Unlike
the previous studies we evaluated both posttreatment and
relatively long-term (2 months after treatment) results.
Clinical findings and symptoms are related to changes
occurring in intraarticular and periarticular structures.
The deep heating effect of therapeutic US, especially on
the periarticular structures, might be responsible for the
improvements achieved in patients in the US groups.
Obviously, studies with longer follow-ups are needed to
evaluate the long-term efficacy of therapeutic US in the
management of knee OA.
Kalpakçıoğlu et al. conducted a randomized clinical
study, which included 15 patients in 2 groups, and applied
isometric quadriceps exercises as well as US treatment for
15 days to one group and short wave diathermy modality
to the other. Functional evaluations were made in terms of
VAS pain scores and WOMAC index at baseline and at the

end of the treatment. Statistically significant improvement
was observed in both groups in terms of pain and function,
and no significant difference was determined between the
2 groups. US treatment applied together with an isometric
quadriceps exercise program resulted in significant
recovery in terms of pain and functional state in knee OA,
which is consistent with the results of our study (13).
Lequesne pain, walking distance, daily life activity, and
index scores for the placebo group were significantly higher
than in the continuous and pulsed US groups at the end of
the treatment and at the second month after the treatment.
The decrease in Lequesne pain, walking distance, daily life
activity, and index scores in the continuous and pulsed US
groups were similar at the second month after treatment.
The change in the placebo group was not significant.
The present study demonstrated that both US modalities
provided improvement in functional parameters in
patients with knee OA, with no superiority between
continuous US and pulsed US groups.
In conclusion, application of continuous and pulsed US
resulted in significant recovery in terms of pain, functional
state, and quality of life in patients with knee OA without
obvious superiority between continuous and pulsed US
groups. Therapeutic US can be used as a safe and effective
physical treatment modality in the management of patients
with knee OA. Long-term observation with larger samples
is required to investigate the long-term efficacy.

References
1.

Altman RD, Lozada CJ. Clinical features of osteoarthritis. In:
Hochberg MC, Silman AJ, Smolen JS, Weinblatt ME, Weisman
MH, editors. Rheumatology. 4th ed. Madrid, Spain: Mosby
Elsevier; 2008. pp. 1703–1710.

2.

Peat G, McCarney R, Croft P. Knee pain and osteoarthritis in
older adults: a review of community burden and current use of
primary health care. Ann Rheum Dis 2001; 60: 91–97.

3.

Sarı H, Tüzün Ş, Akgün K. Hareket Sistemi Hastalıklarında
Fiziksel Tıp Yöntemleri. İstanbul, Turkey: Nobel Tıp Kitabevi;
2002 (in Turkish).

4.

Tuncer T. Electrotherapy. In: Beyazova M, Kutsal YG, editors.
Fiziksel Tıp ve Rehabilitasyon. Ankara, Turkey: Güneş Kitabevi;
2000. pp. 35–80 (in Turkish).

5.

Kalyon TA. Ultrasound. In: Tuna N, editor. Elektroterapi.
İstanbul, Turkey: Nobel Tıp Kitabevi; 2001. pp. 52–75 (in
Turkish).

6.

Kellgren JH, Lawrence JS. Radiological assessment of
osteoarthritis. Ann Rheum Dis 1957; 16: 494–502.

7.

Basaran S, Guzel R, Seydaoglu G, Guler Uysal F. Validity,
reliability, and comparison of the WOMAC osteoarthritis
index and Lequesne algofunctional index in Turkish patients
with hip or knee osteoarthritis. Clin Rheumatol 2010; 29: 749–
756.

8.

Aydın R. Dejeneratif Romatizmal Hastalıklar. In: Ketenci
A, Diniz F, editors. Fiziksel Tıp ve Rehabilitasyon. İstanbul,
Turkey: Nobel Tıp Kitabevi; 2000. pp. 331–342 (in Turkish).

9.

ACR Subcommittee. Recommendations for the medical
management of osteoarthritis of the hip and knee: 2000 update.
Arthritis Rheum 2000; 43: 1905–1915.

10.

Falconer J, Hayes KW, Chang RW. Effect of ultrasound on
mobility in osteoarthritis of the knee. A randomized clinical
trial. Arthritis Care Res 1992; 5: 29–35.

11.

Huang MH, Lin YS, Lee CL, Yang RC. Use of ultrasound
to increase effectiveness of isokinetic exercise for knee
osteoarthritis. Arch Phys Med Rehabil 2005; 86: 1545–1551.

12.

Özgönenel L, Aytekin E, Durmuşoğlu G. A double blind trial of
clinical effects of therapeutic ultrasound in knee osteoarthritis.
Ultrasound Med Biol 2009; 35: 44–49.

13.

Kalpakçıoğlu A, Çakmak B, Bahadır C. Comparison of
ultrasound and short wave diaterm in knee osteoarthritis. Turk
J Phys Med Rehab 2006; 52: 168–173.

1191

